Xenobiotica

the fate of foreign compounds in biological systems

Volume 43, 2013 - Issue 11

348

Views

CrossRef citations to date

Altmetric

Research Article

Elucidation of the biochemical basis for a clinical drug–drug interaction between atorvastatin and 5-(N-(4-((4-ethylbenzyl)thio)phenyl)sulfamoyl)-2-methyl benzoic acid (CP-778 875), a subtype selective agonist of the peroxisome proliferator-activated receptor alpha

Amit S. KalgutkarPharmacokinetics, Dynamics and Metabolism Department Pfizer Inc., Cambridge, MAUSACorrespondence[email protected]

Danny ChenClinical Pharmacology, Pfizer Inc. Cambridge, MAUSA

Manthena V. VarmaPharmacokinetics, Dynamics and Metabolism Department Pfizer Inc., Groton, CTUSA

Bo FengPharmacokinetics, Dynamics and Metabolism Department Pfizer Inc., Groton, CTUSA

Steven G. TerraCardiovascular, Metabolic and Endocrine Diseases Unit Pfizer Inc., Cambridge, MAUSA

Renato J. ScialisPharmacokinetics, Dynamics and Metabolism Department Pfizer Inc., Groton, CTUSA

Charles J. RotterPharmacokinetics, Dynamics and Metabolism Department Pfizer Inc., Groton, CTUSA

Kosea S. FrederickPharmacokinetics, Dynamics and Metabolism Department Pfizer Inc., Groton, CTUSA

Mark A. WestPharmacokinetics, Dynamics and Metabolism Department Pfizer Inc., Groton, CTUSA

Theunis C. GoosenPharmacokinetics, Dynamics and Metabolism Department Pfizer Inc., Groton, CTUSA

James R. GossetClinical Pharmacology, Pfizer Inc. Cambridge, MAUSA

Robert L. WalskyPharmacokinetics, Dynamics and Metabolism Department Pfizer Inc., Groton, CTUSA

Omar L. FranconeCardiovascular, Metabolic and Endocrine Diseases Unit Pfizer Inc., Cambridge, MAUSA

show all

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (7)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Elucidation of the biochemical basis for a clinical drug–drug interaction between atorvastatin and 5-(N-(4-((4-ethylbenzyl)thio)phenyl)sulfamoyl)-2-methyl benzoic acid (CP-778 875), a subtype selective agonist of the peroxisome proliferator-activated receptor alpha

Articles from other publishers (7)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Elucidation of the biochemical basis for a clinical drug–drug interaction between atorvastatin and 5-(N-(4-((4-ethylbenzyl)thio)phenyl)sulfamoyl)-2-methyl benzoic acid (CP-778 875), a subtype selective agonist of the peroxisome proliferator-activated receptor alpha

Citations (7)

Articles from other publishers (7)

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date